Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-21), PCC Rokita's 14-Day RSI is 64.84.
The industry rank for PCC Rokita's 14-Day RSI or its related term are showing as below:
WAR:PCR's 14-Day RSI is ranked worse than 94.3% of 1650
companies
in the Chemicals industry
Industry Median: 43.06
vs WAR:PCR: 64.84
PCC Rokita (WAR:PCR) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
PCC Rokita 14-Day RSI Related Terms
WAR:PCR vs DOW: 14-Day RSI Comparison
For the Chemicals subindustry, PCC Rokita's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PCC Rokita 14-Day RSI vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, PCC Rokita's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where PCC Rokita's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PCC Rokita (WAR:PCR) has a 14-Day RSI of 64.84 as of Jul. 21, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on PCC Rokita and its competitors. According to the industry distribution chart, PCC Rokita ranks #1556 out of 1650 companies in the Chemicals industry, placing it in the top 94.3%.
Is PCC Rokita's 14-Day RSI too high?
PCC Rokita's current 14-Day RSI is 64.84. The Chemicals industry median 14-Day RSI is 43.06. PCC Rokita's value of 64.84 is 50.6% above this industry median. Based on the distribution chart, PCC Rokita ranks #1556 out of 1650 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, PCC Rokita has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PCC Rokita's 14-Day RSI compare to DOW?
According to the Chemicals industry distribution chart, PCC Rokita ranks #1556 out of 1650 companies for 14-Day RSI. This places PCC Rokita in the lower half of its industry. The industry median 14-Day RSI is 43.06. PCC Rokita's value of 64.84 is 50.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Chemicals company?
The median 14-Day RSI among Chemicals companies is 43.06, based on 1,650 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PCC Rokita's current 14-Day RSI of 64.84 is 50.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on PCC Rokita and its competitors. For the Chemicals industry, the median 14-Day RSI is 43.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PCC Rokita's current 14-Day RSI is 64.84. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PCC Rokita stock overvalued right now?
Based on GuruFocus' analysis, PCC Rokita (WAR:PCR) is currently considered Fairly Valued. The stock's GF Value™ is zł66.24, compared to a current price of zł69.50 — trading 4.9% above its estimated fair value. The current 14-Day RSI is 64.84 and 50.6% above the Chemicals industry median of 43.06. PCC Rokita's overall GF Score™ is 82/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For PCC Rokita (WAR:PCR), the current 14-Day RSI is 64.84 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PCC Rokita (WAR:PCR) Overvalued in 2026?
Based on GuruFocus' analysis, PCC Rokita stock appears to be overvalued.
The current stock price of zł69.50 is trading 4.9% above its estimated GF Value™ of zł66.24.
GuruFocus considers PCC Rokita to be Fairly Valued.
Key valuation signals for WAR:PCR:
14-Day RSI: 64.84
GF Value™: zł66.24 vs. price of zł69.50 (4.9% above fair value)
Industry Position: 50.6% above the Chemicals median (#1556 of 1650)
No single metric tells the full story. See the WAR:PCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PCC Rokita SA is engaged in manufacturing chemicals. Its products include Polyols, Chloralkali, Chlorobenzene, Phosphorus derivatives, and Naphthalene derivatives. It serves adhesives, agrochemicals, building and construction, case, detergents, fire prevention, food and fuel industry, furniture, I&I cleaning, lubricants and functional fluids, metallurgical, mining and drilling, oilfield, paints and coatings, personal care, pharmaceuticals, plastics, power, printing ink, pulp and paper, raw materials and intermediates, refrigeration and household appliances, sports and recreation, tanning and textile, transportation, and water and wastewater treatment industries.
82GF Score
Get the complete analysis for WAR:PCR
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:PCR has been successfully added to your 
